One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia

M. Diamant, M. Poelma, D.L. Goede, L.W. van Golen, R.E. van Genugten, E.M. Eekhoff, A. Schweizer, R.J. Heine, J.E. Foley, G. Nijpels, M.C.M. Bunck

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)A192-A193
JournalDiabetes
Volume59
Publication statusPublished - 2010

Cite this